AXIM BiotechnologiesAXIM 3-Year ROIIC % is 291.45 as of Dec. 2024. The stock has 7 warning signs investors should review. Among 1,325 Biotechnology companies, AXIM Biotechnologies ranks better than 87.55% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
AXIM Biotechnologies's 3-Year ROIIC % for the quarter that ended in Dec. 2024 was 291.45%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for AXIM Biotechnologies's 3-Year ROIIC % or its related term are showing as below:
AXIM's 3-Year ROIIC % is ranked better than 87.55% of 1325
companies
in the Biotechnology industry
Industry Median: -4.82
vs AXIM: 291.45
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
AXIM Biotechnologies 3-Year ROIIC % Related Terms
AXIM Biotechnologies 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for AXIM Biotechnologies's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AXIM vs HEPA, SCNI, BZYR: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, AXIM Biotechnologies's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AXIM Biotechnologies 3-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where AXIM Biotechnologies's 3-Year ROIIC % falls into.
AXIM Biotechnologies's 3-Year ROIIC % for the quarter that ended in Dec. 2024 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -1.763 (Dec. 2024) - -7.729 (Dec. 2021) )
/
( 8.371 (Dec. 2024) - 6.324 (Dec. 2021) )
=
5.966
/
2.047
=
291.45%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
AXIM Biotechnologies (AXIM) has a 3-Year ROIIC % of 291.45 as of Dec. 2024. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on AXIM Biotechnologies and its competitors. According to the industry distribution chart, AXIM Biotechnologies ranks #165 out of 1325 companies in the Biotechnology industry, placing it in the top 12.5%.
Is AXIM Biotechnologies' 3-Year ROIIC % too high?
AXIM Biotechnologies' current 3-Year ROIIC % is 291.45. Based on the distribution chart, AXIM Biotechnologies ranks #165 out of 1325 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does AXIM Biotechnologies' 3-Year ROIIC % compare to HEPA and SCNI?
According to the Biotechnology industry distribution chart, AXIM Biotechnologies ranks #165 out of 1325 companies for 3-Year ROIIC %. This places AXIM Biotechnologies in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on AXIM Biotechnologies and its competitors. AXIM Biotechnologies's current 3-Year ROIIC % is 291.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current 3-Year ROIIC % of 291.45. The current 3-Year ROIIC % is 291.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current 3-Year ROIIC % is 291.45 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AXIM has been successfully added to your 